Head injury therapies

Bibliography

• GOLDSTEIN M: Traumatic brain injury: a silent epi-demic. Ann. Neurol (1990) 27:327.
   PubMed Web of Science ®Google Scholar
• POPE AM, TAILOR AR: Disability in America: towards a national agenda for prevention. Academic Press, Wash-ington, DC (1991).
   Google Scholar
• GRAHAM DI, TORA I, ADAMS JH et al: Ischaemic damage •is still common in fatal non-missile head injury. J. Neurol Neurosurg. Psych. (1989) 52:346–350.
   Google Scholar
• A paper confirming the importance of ischaemic damage in human head injury.
   Google Scholar
• JENKINS LW, MOSZYNSKI K, LYETH BG et al.: Increased vulnerability of the mildly traumatised rat brain to cerebral ischaemia: the use of controlled secondary ischaemia as a research tool to identify common or different mechanisms contributing to mechanical and ischaemic brain injury. Brain Res. (1989) 477:211-244. Experimental demonstration of the important interaction between mechanical brain damage and 'secondary insults', such as hypoten-sion.
   Google Scholar
• GRAHAM DI, ADAMS JH, DOYLE D: Ischaemic brain damage in fatal non-missile head injuries. J. Neurol. ScL (1978) 39:213–234.
   PubMed Web of Science ®Google Scholar
• GRAHAM DI, GENNARELLI TA: Trauma. In: Greenfield's Neuropathology (6th Edition). Graham DI, Lantos PL (Eds.), Arnold, London (1996) 197–262.
   Google Scholar
• DOPPENBERG EMR, BULLOCK R: Clinical neuro-protec- tion trials in severe traumatic brain injury: lessons fromprevious studies. J. Neurotrauma (1997) 14:71-80. Review of recent trials and discussion of some of the issues that may have contributed to the limited clinical benefits seen so far.
   Google Scholar
• POVLISHOCK JT, CHRISTMAN CW: The pathobiology oftraumatically induced axonal injury in animals and humans: a review of current thoughts. J. Neurotrauma (1995) 12:255–264.
   Google Scholar
• MAXWELL WL, WATTS C, GRAHAM DI, GENNARELLI TA: Ultrastructural evidence of axonal shearing as a result of lateral acceleration of the head in non-human pri-mates. Acta Neuropathol. (1993) 86:136–144.
   PubMed Web of Science ®Google Scholar
• GENNARELLI TA: The pathobiology of traumatic brain injury. Neuroscientist (1997) 3:73-81. Up-to-date review of current concepts of the pathobiology of head injury.
   Google Scholar
• MCINTOSH TK, SMITH DH, MEANEY DF et al.:
   Google Scholar
• •Neuropathological sequelae of traumatic brain injury: relationship to neurochemical and biomechanical mechanisms. Lab. Invest. (1996) 74:315-342. Recent review of neuropathological and biochemical changes asso-ciated with experimental brain injury.
   Google Scholar
• OMMAYA AK, THIBAULT LE, BANDAK F: Mechanics ofimpact head injury. Int. J. Impact Eng]. (1994) 15:535–560.
   Web of Science ®Google Scholar
• MEANEY DF, SMITH DH, ROSS DT, GENNARELLI TA: Dif-fuse axonal injury in the miniature pig: biomechanical development and injury threshold. AMP (1993) 169:169–175.
   Google Scholar
• KAMPFEL A, POSMANTUR RM, ZHAO X eta].: Mechanisms •of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: a review and update. J. Neurotrauma (1997) 14:121-134. Review of evidence for overactivity of calpains after head injury and potential for calpain inhibitors to attenuate injury-induced damage.
   Google Scholar
• WINSTON FK, MACARAK EJ, THIBAULT LE: An analysis of the time dependent changes in intracellular calcium concentration in endothelial cells in cell culture. J. Biomech. Engl. (1993) 115:160–168.
   PubMed Web of Science ®Google Scholar
• MATTSON MP, SCHEFF SW: Endogenous neuroprotec-tion factors and traumatic brain injury: mechanisms of action and implications for therapy. J. Neurotrauma (1994) 11:3–33.
   PubMed Web of Science ®Google Scholar
• SAATMAN KE, MCINTOSH TK: Regional and focal altera-tions in neurofilament and tubulin immunoreactivity in injured rat brain. Soc. Neurosci. Abstr. (1994) 20:115.
   Google Scholar
• GENTLEMAN SM, ROBERTS GW, GENNARELLI TA et al.:Axonal injury: a universal consequence of fatal closed head injury? Acta Neuropathol (1995) 83:537–543.
   Google Scholar
• JIANG JY, LYETH BG, DELAHUNTY TM, PHILLIPS LL, HAMM RJ Muscarinic cholinergic receptor binding in rat brainat 15 days following traumatic brain injury. Brain Res. (1994) 651:123–128.
   PubMed Web of Science ®Google Scholar
• MCINTOSH TK, YU T, GENNARELLI TA: Alterations inregional brain catecholamine concentrations after ex-perimental brain injury. J. Neurochem. (1994) 63:1426–1433.
   PubMed Web of Science ®Google Scholar
• MCINTOSH TK, HEAD VA, FADEN Al: Alterations in re-gional concentrations of endogenous opioids following traumatic brain injury in the cat. Brain Res. (1987) 425:225–233.
   PubMed Web of Science ®Google Scholar
• PALMER AM, MARION DW, BOTSCHELLER ML et al.: Trau-matic brain injury-induced excitotoxicity in a control-led cortical impact model. J. Neurochem. (1993) 61:2015–2024.
   Google Scholar
• ROTHMAN SM, OLNEY JW: Excitotoxicity and the NMDA receptor. Trends Neurosci. (1987) 10:299–302.
   Web of Science ®Google Scholar
• BUCHAN AM: Do NMDA antagonists protect against cerebral ischaemia: are clinical trials warranted? Cere-brovasc. Brain Metab. Rev. (1990) 2:1–26.
   PubMedGoogle Scholar
• MELDRUM B: Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmis-sion. Cerebrovasc. Brain Metab. Rev. (1990) 2:27–57.
   PubMedGoogle Scholar
• TOWER D, MCEACHERN D: Acetylcholine and neuronal activity in craniocerebral trauma. J. Clin. Invest. (1948) 27:558–559.
   PubMed Web of Science ®Google Scholar
• BORNSTEIN M: Presence and action of acetylcholine inexperimental brain trauma. J. Neurophysiol (1946) 9:349–366.
   PubMed Web of Science ®Google Scholar
• LYETH BG, JIANG JY, DELAHUNTY TM, PHILLIPS LL, HAMMRJ: Muscarinic cholinergic receptor binding in rat brain following traumatic brain injury. Brain Res. (1994) 640:240–245.
   PubMed Web of Science ®Google Scholar
• LYETH BG, DIXON CE, HAMM R et al.: Effects of an-ticholinergic treatment on transient behavioural sup-pression and physiological responses following concussive brain injury to the rat. Brain Res. (1988) 488:88–97.
   Google Scholar
• PAPPIUS HM, DADOUN R: Effects of injury on the indo-leamines in cerebral cortex.' Neurochem. (1987) 49:321–325.
   PubMed Web of Science ®Google Scholar
• MCINTOSH TK, FERNYAK S, YAMAKAMI I, FADEN Al: Central and systemic x-opioid agonists exacerbate neurobehavioral response to brain injury in rats. Am. J. Physic)]. (1994) 267:R665–R672.
   Web of Science ®Google Scholar
• HALL E, WOLF DL, ALTHAUS JS, VON VOIGTLANDER PF: Beneficial effects of the x-opioid receptor agonist U50,48811 in experimental acute brain and spinal cord injury. Brain Res. (1987) 435:174–180.
   PubMed Web of Science ®Google Scholar
• FADEN Al: Dynorphin increases extracellular levels of excitatory amino acids in the brain through a nonopioid mechanism. J. Neurosci. (1992) 12:425–429.
   PubMed Web of Science ®Google Scholar
• QUATTROCCHI KB, FRANK EH, MILLER CH eta].: Suppres-sion of cellular immune activity following severe head injury. J. Neurotrauma (1990) 7:77–87.
   Google Scholar
• BIAGAS KV, UHL MW, SCHIDING JK, NEMOTO EM, KO-CHANEK PM: Assessment of the posttraumatic polymor-phonuclear leukocyte accumulation in rat brain using tissue myeloperoxidase assay and vinblastine treat-ment. J. Neurotrauma (1992) 9:363–371.
   PubMed Web of Science ®Google Scholar
• SCHOETTLE RJ, KOCHANEK PM, MAGAREE MJ, UHL MW,NEMOTO EM: Early polymorphonuclear leukocyte ac-cumulation correlates with the development of post-traumatic cerebral oedema in rats. J. Neurotrauma (1990) 7:207–217.
   PubMedGoogle Scholar
• OTT L, MCCLAIN CJ, GILLESPIE M, YOUNG B: Cytokinesand metabolic dysfunction after severe head injury. J. Neurotrauma (1994) 11:447–472.
   PubMed Web of Science ®Google Scholar
• WOODROOFE MN, SARNA GS, WADHWA M: Detection ofinterleukin-1 and interleukin-6 in adult rat brain, fol-lowing mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J. Neuroimmunol (1991) 33:227–236.
   PubMed Web of Science ®Google Scholar
• MCCLAIN C, COHEN D, PHILLIPS R, OTT L, YOUNG B:Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J. Lab. Clin. Med. (1991) 118:225–231.
   PubMed Web of Science ®Google Scholar
• GOODMAN JC, ROBERTSON CS, GROSSMAN RG, NARAYAN RK: Elevation of tumour necrosis factor in head injury. J. Neuroimmunol (1990) 30:213–217.
   PubMed Web of Science ®Google Scholar
• FAN L, YOUNG PR, BARONE FC et al: Experimental braininjury induces expression of interleukin-113 mRNA in the rat brain. Mol Brain Res. (1995) 30:125–130.
   PubMedGoogle Scholar
• LESLIE JB, WATKINS WD: Eicosanoids in the centralnervous system. J. Neurosurg. (1985) 63:659–668.
   PubMed Web of Science ®Google Scholar
• KONTOS HA, POVLISHOK JT: Oxygen radicals in braininjury. CNS Trauma (1986) 3:257–263.
   Google Scholar
• MORGANTI-KOSSMANN MC, KOSSMANN T, WAHL SM: Cytokines and neuropathology. Trends Pharmacol Sci. (1992) 13:286–291.
   PubMed Web of Science ®Google Scholar
• HAYES RL, YANG K, RAGHUPATHI R, MCINTOSH TK: •Changes in gene expression following traumatic brain injury in the rat. J. Neurotrauma (1995) 12:791-814. Evidence for the activation of immediate early genes after head injury.
   Google Scholar
• BAZAN MG, RODRIGUEZ DE TURCO EB, ALLAN G: Media- •tors of injury in neurotraurna: intracellular signal transduction and gene expression. J. Neurotrauma (1995) 12:791-814. More recent review of early genome events after head injury.
   Google Scholar
• DMELLO SR, HEINRICH G: Structural and functional identification of regions and cis elements surrounding the nerve growth factor gene promoter. Mol Brain Res. (1991) 11:255–264.
   PubMedGoogle Scholar
• CHOPP M: The role of heat shock proteins and immedi-ate early genes in central nervous system normal func-tion and pathology. CUIT. Opin. Neurol Neurosurg. (1993) 15:467–473.
   Google Scholar
• RINK AD, FUNG KM, TROJANOWSKI JQ et al.: Evidence of •apoptotic cell death after experimental traumatic brain injury in the rat. Am. J. Pathol (1995) 147:1575-1583. Evidence that programmed cell death may play a role in cell death after mechanical injury.
   Google Scholar
• GINSBERG MD, STERNAU LL, GLOBUS MYT, DIETRICH WD, BUSTO R: Therapeutic modulation of brain tem-perature: relevance to ischaemic brain injury. Cere-brovasc. Brain Metab. Rev (1992) 4:189–225.
   PubMedGoogle Scholar
• HOFFMAN WE, THOMAS C: Effects of graded hypother-mia on outcome from brain ischaemia. Neurol. Res. (1996) 18:185–189.
   PubMed Web of Science ®Google Scholar
• SHIOZAKI T, SUGIMOTO H, TANEDA M, YOSHIDA H, SUGIMOTO T: Effect of mild hypothermia on uncon-trollable intracranial hypertension after severe head injury. J. Neurosurg. (1993) 79:363–368.
   PubMed Web of Science ®Google Scholar
• CLIFTON GL, ALLEN S, BARRODALE P et al.: A Phase II study of moderate hypothermia in severe brain injury. Neurotrauma (1993) 10:263–271.
   PubMed Web of Science ®Google Scholar
• MARION DW, OBRIST WD, CARLIER PM, PENROD LE, DARBY JM: The use of moderate therapeutic hypother-mia for patients with severe head injury: a preliminary report. J. Neurosurg. (1993) 79:354–362.
   PubMed Web of Science ®Google Scholar
• CLIFTON GL: Systemic hypothermia in treatment of •severe brain injury: a review and update. J. Neurotrauma (1996) 12:923-927. A review of experimental evidence and clinical trials using hypother-mia in head injury.
   Google Scholar
• GORDON E: Some correlations between the clinical outcome and the add-base status of blood and cerebro-spinal fluid in patients with traumatic brain injury. Acta Anaesthesiol Scand. (1971) 15:209–228.
   PubMed Web of Science ®Google Scholar
• YOSHIDA K, CORWIN F, MARMAROU A: Effect of THAM on brain oedema in experimental brain injury. Acta Neurochirurgica (1990) 51:317–319.
   Google Scholar
• WOLF AL, LEVI I, MARMAROU A et al.: Effect of THAM upon outcome in severe head injuries: a randomised prospective clinical trial. J. Neurosurg. (1993) 78:54–59.
   PubMedGoogle Scholar
• JOHNSTON IH, HARPER AM: The effect of mannitol on cerebral blood flow. J. Neurosurg (1973) 38:461–471.
   PubMed Web of Science ®Google Scholar
• ZORNOW MH, OH YS, SCHELLER MS: A comparison of the cerebral and haemodynamic effects of mannitol and hypertonic saline in an animal model of brain injury. Acta Neurochir Suppl Wein (1990) 51:324–325.
   PubMedGoogle Scholar
• SCHWARTZ ML, TATOR CH, ROWED DW et al: The Uni-versity of Toronto Head Injury Treatment Study: a prospective randomised comparison of pentobarbital and mannitol. Can. J. Neurol. ScL (1984) 11:434–440.
   PubMed Web of Science ®Google Scholar
• SMITH HP, KELLY DL, MCWHORTER JM et al.: Comparison of mannitol regimens in patients with severe head injury undergoing intracranial pressure monitoring. J. Neurosurg (1986) 65:820–824.
   PubMed Web of Science ®Google Scholar
• MILLER JD, PIPER IR, DEARDEN NM: Management of intracranial hypertension in head injury: matching treatment with cause. Acta Neurochir SuppL Wein (1993) 57:152–159.
   PubMedGoogle Scholar
• NORDSTROM C-H, MESSETER K, SUNDBARG G, SHALENW, RYDING E: Cerebral blood flow, vasoreactivity and oxygen consumption during barbiturate therapy in severe traumatic brain lesions. J. Neurosurg. (1988) 68:424–431.
   PubMed Web of Science ®Google Scholar
• FLAMM ES, DEMOPOULOS HB, SELIGMAN ML, RANSO-HOFF J: Possible molecular mechanisms of barbiturate-mediated protection in regional cerebral ischaemia. Acta Neurol. Scand. (1977) 56\(Suppl. 64):150–151.
   Google Scholar
• DEMOPOULOS HB, FLAMM ES, SELIGMAN ML, JORGENSEN E, RASNOHOFF J: Anti-oxidant effects of barbiturates in model membranes undergoing free radical damage. Acta Neurol. Scand. (1977) 56\(Suppl. 64):152–153.
   Google Scholar
• SCHALEN W, MESSETER K, NORDSTROM C-H: Complica-tions and side effects during thiopentone therapy in patients with severe head injuries. Acta Anaesthsiol Scand. (1992) 36:369–377.
   PubMed Web of Science ®Google Scholar
• REA GL, ROCKSWOLD GL: Barbiturate therapy in uncontrolled intracranial hypertension. Neurosurgery (1983) 12:401–404.
   PubMed Web of Science ®Google Scholar
• EISENBERG HM, FRANKOWSKI RF, CONTANT CF, MAR-SAHLL LF, WALKER MD: High dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J. Neurosurg. (1988) 69:15–23.
   PubMed Web of Science ®Google Scholar
• WARD JD, BECKER DP, MILLER JD et al.: Failure of pro-phylactic barbiturate coma in the treatment of severe head injury. J. Neurosurg. (1983) 62:383–388.
   Web of Science ®Google Scholar
• HALL ED: The neuroprotective pharmacology of methylpredniosolone. j Neurosurg. (1992) 76:13–22.
   PubMed Web of Science ®Google Scholar
• HALL ED: High-dose glucocorticoid treatment improves neurological recovery in head-injured mice. J. Neuro-surg. (1985) 62:882–887.
   Google Scholar
• BRACKEN MC, SHEPARD MJ, COLLINS W eta].: A random- •ised controlled trial of methylprednisolone or nalox-one in the treatment of acute spinal cord injury. Results of the Second National Acute Spinal Cord Injury Study. New Engl. J. Med. (1990) 332:1405-1411. A multicentre trial showing benefit for methylprednisolone admini-stration within 8 h of spinal cord injury.
   Google Scholar
• GRUMME T, BAETHMANN A, KOLODZIEJCZYK D: Treat- •ment of patients with severe head injury by triamci-nolone: a prospective controlled multicenter clinical trial of 396 cases. Res. Exp. Med. (Berlin) (1995) 195:217-229. Lower mortality in subgroups with focal lesions and GCS less than 8.
   Google Scholar
• ALDERSON P, ROBERTS I: Corticosteroids in acute traumatic brain injury: systematic review of randomised controlled trials. Br. Med. J. (1997) 314:1855-1859. Meta-analysis of clinical trials of corticosteroids in head injury.
   Google Scholar
• HALL ED, YONKERS PA, MCCALL JM, BRAUGHLER JM: Effect of the 21 amino steroid U-74006F on experimen-tal head injury in mice. J. Neurosurg. (1988) 68:456–461.
   PubMed Web of Science ®Google Scholar
• TAYLOR BM, FLEMING WE, BENJAMIN CW et al: The mechanism of cytoprotective action of lazaroids I: In-hibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion. J. Phar-macol Exp. Ther. (1996) 276:1224–1231.
   PubMed Web of Science ®Google Scholar
• MARSHALL LF, MARSHALL SB: Pitfalls and advances fromthe international tirilizad trial in moderate and severe head injury. J. Neurotrauma (1995) 12:929–932.
   PubMed Web of Science ®Google Scholar
• MCKINNEY JS, WILLOUGHBY KA, HANG S, ELLIS EF: Stretch induced injury of cultured neuronal, glial and endothelial cells. Effect of polyethylene glycol conju-gated superoxide dismutase. Stroke (1996) 22:934–940.
   Google Scholar
• LIU TH, BECKMAN JS, FREEMAN BA: Polyethylene glycol conjugated superoxide dismutase and catalase reduce ischaemic brain injury. Am. J. Physic)]. (1989) 56:H589–H593.
   Google Scholar
• CHAN P, LONGAR S, FISHMAN R: Protective effects of liposome entrapped superoxide dismutase on post traumatic brain oedema. Ann. Neurol. (1987) 21:540–547.
   PubMed Web of Science ®Google Scholar
• MUIZELAAR JP, MARMAROU A, YOUNG HF et al.: Improv-ing the outcome of severe head injury with the oxygen radical scavenger polyethylene glycol conjugated su-peroxide dismutase: a phase II trial. J. Neurosurg. (1993) 78:375–382.
   PubMed Web of Science ®Google Scholar
• YOUNG B, RUNGE JW, WAXMAN KS et al: Effects of pergotein on neurologic outcome of patients with se-vere head injury. A multicenter, randomized controlled trial. JAMA (1996) 276:538–543.
   Google Scholar
• MCINTOSH TK: Novel pharmacologic therapies in thetreatment of experimental traumatic brain injury: a review. J. Neurotrauma (1993) 10:215–261.
   PubMed Web of Science ®Google Scholar
• JENSEN K, OHRSTROM J, COLD GE, ASTRUP J: The effects of indomethacin on intracranial pressure, cerebral blood flow and cerebral metabolism in patients with severe head injury and intracranial hypertension. Acta Neurochirurgica (1991) 108:116–121.
   PubMed Web of Science ®Google Scholar
• MOHAMED AA, GOTOH O, GRAHAM DI et al: Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion. Ann. Neurol. (1985) 18:705–711.
   PubMed Web of Science ®Google Scholar
• HADLEY MN, ZABRANSKI JM, SPETZLER RF et al.: The efficacy of intravenous nimodipine in the treatment of focal cerebral ischaemia in a primate model. Neurosur-gery (1989) 25:63–70.
   PubMed Web of Science ®Google Scholar
• SINAR EJ, MENDELOW AD, GRAHAM DI, TEASDALE GM: Experimental intracerebral haemorrhage: the effect of nimodipine pretreatment. J. Neurol. Neurosurg. Psych (1988) 51:651–662.
   PubMed Web of Science ®Google Scholar
• BAILEY I, BELL A, GRAY J et al.: A randomised trial of the •effect of nimodipine on outcome after head injury. Acta Neurochirurgica (1991) 110:97-105. 'HIT I'.
   Google Scholar
• AUTHORS: A multicenter trial of the efficacy of nimodip- •me on outcome after severe head injury. The European Study Group on Nimodipine in Severe Head Injury. J. Neurosurg. (1994) 80:797-804. 'HIT II'.
   Google Scholar
• HARDERS A, KAKARIEKA A, BRAAKMAN R: Traumatic subarachnoid haemorrhage and its treatment with ni-modipine. German TSAH Study Group. J. Neurosurg. (1996) 85:82–89.
   Google Scholar
• BULLOCK R, ZAUNER A, MYSEROS JS et al.: Evidence for prolonged release of excitatory amino acids in severe head trauma. Relationship to clinical events. Ann. NY Acad. Sci. (1995) 765:290–297.
   PubMed Web of Science ®Google Scholar
• ZAUNER A, BULLOCK R, KUTA AJ, WOODWARD J, YOUNG HF: Glutamate release and cerebral blood flow after severe head injury. Acta Neurochk. Suppl. Wein (1996) 67:40–44.
   PubMedGoogle Scholar
• BULLOCK R, GRAHAM DI, CHEN M-H, LOWE D, MCCUL-LOCH J: Focal cerebral ischaemia in the cat: pretreat-ment with a competitive NMDA receptor antagonist, D-CPP-ene. J. Cerebrovasc. Blood Flow Metab. (1990) 10:668–674.
   PubMed Web of Science ®Google Scholar
• PULSINELLI W, SAROKIN A, BUCHAN A: Antagonism of the NMDA and non-NMDA receptors in global vs focal brain ischaemia. Prog. Brain Res (1993) 96:125–135.
   PubMed Web of Science ®Google Scholar
• CHEN M-H, BULLOCK R, GRAHAM DI, MILLER JD, MCCUL-LOCH J: Ischaemic neuronal damage after acute sub-dural haematoma in the rat: effects of pretreatment with a glutamate antagonist. J. Neurosurg. (1991) 74:944–950.
   PubMed Web of Science ®Google Scholar
• MUIR KW, LEES KR: Clinical experience with excitatory amino acid antagonist drugs. Stroke (1995) 26:503-513. Review of clinical experience with glutamate antagonists, focusing on stroke.
   Google Scholar
• OLNEY JW, LABRUYERE J, PRICE MT: Pathological changes induced in cerebrocortical neurones by phencyclidenes and related drugs. Science (1989) 244:1360–1362.
   PubMed Web of Science ®Google Scholar
• CHOI DW: Methods for antagonising glutamate neuro-toxicity. Cerebrovasc. Brain Met. Rev. (1990) 2:105–147.
   PubMedGoogle Scholar
• BULLOCK R: Strategies for neuroprotection with gluta-mate antagonists. Extrapolating from evidence taken from the first stroke and head injury studies. Ann. NY Acad. Sci. (1995) 765:272–278.
   Google Scholar
• DAVIS SM, ALBERS GW, DIENER HC, LEES KR, NORRIS J: Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST steering committee. Lancet (1997) 349:32.
   PubMed Web of Science ®Google Scholar
• WAGSTAFF A, TEASDALE GM, CLIFTON G, STEWART L: The cerebral, haemodynamic and metabolic effects of the noncompetitive NMDA antagonist CNS1102 in hu-mans with severe head injury. Ann. NY Acad. Sci (1995) 765:332–333.
   PubMedGoogle Scholar
• TOULMOND S, SERRANO A, BENAVIDES J, SCATTON B: Neuroprotective effects of SL-820715 in an experimen-tal model of brain trauma. J. Cerebrovasc. Blood How Metab. (1991) 11:S313.
   Google Scholar
• MAREK P, EILON G, KEANA J, WEBER E: The neuropro-tective effect of the NMDA receptor glycine site antago-nist ACEA-1021 (6,7-dichloro-5-nitro- 1,4-dihydro-2,3-quinozalinedione) in a rat model of focal cerebral ischaemia. Can. J. Physiol. Pharmacol (1994) 72\(Suppl. 1):P13.20.26.
   Google Scholar
• BENSIMON G, LACOMBLEZ L, MEININGER V: A controlled trial of riluzole in amyotrophic lateral sclerosis. New Engl. J. Med. (1994) 330:585–591.
   PubMed Web of Science ®Google Scholar
• JENNETT B, BOND M: Assessment of outcome after severe brain damage. A practical scale. Lancet (1975) 1:480–484.
   PubMed Web of Science ®Google Scholar
• HALL K, COPE DN, RAPPAPORT M: Glasgow Outcome Scale and Disability Rating Scale: comparative useful-ness in following recovery in traumatic head injury. Arch. Physic. Med. Rehabilit (1985) 66:35–37.
   PubMed Web of Science ®Google Scholar
• GOUVIER WD, BLANTON PD, LAPORTE KK et al.: Reliabil-ity and validity of the Disability Rating Scale and the Levels of Cognitive Functioning Scale in monitoring recovery from severe head injury. Arch. Physic. Med. Rehabilit. (1987) 68:94–97.
   PubMed Web of Science ®Google Scholar
• JENNETT B, SNOEK J, BOND MR et al.: Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J. NeuroL Neurosurg Psych. (1981) 44:285–293.
   PubMed Web of Science ®Google Scholar
• ANDERSON SI, HOUSLEY AM, JONES PA, SLATTERY J, MILLER JD: Glasgow Outcome Scale: an inter-rater reli-ability study. Brain Injury (1993) 7:309–317.
   PubMedGoogle Scholar